SEPN (Septerna, Inc.) Sof foyda

SEPN (Septerna) - kompaniyaning tovar belgisi

Septerna Inc (SEPN) ilg'or GPCR retseptor metodologiyalaridan foydalangan holda endokrinologlar va onkologlar uchun innovatsion dori vositalarini ishlab chiqadi. GURU.Markets platformasidagi ushbu tarixiy narxlar grafigi, unda ko'rsatkich -0.03 darajasida turibdi, texnologik muvaffaqiyatni yuqori bonuslar bilan jalb qilingan yetakchi olimlar jamoasi bilan bog'laydi. Biznes model proprietary AI tizimiga tayanadi, u esa ulkan R&D xarajatlari va FDA talablari bilan birgalikda, yangi ishtirokchilar uchun yengib bo'lmas kirish to'sig'ini yaratadi.

SEPN (Septerna Inc) Sof foyda tarixi 26.10.2024dan 29.10.2026gacha

Septerna (SEPN) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Septerna Pharma|SEPN - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Septerna Pharma|SEPN - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Septerna|SEPN - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi septerna.com|SEPN - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Septerna Inc|SEPN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Septerna, Inc.|SEPN - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Septerna Pharma|SEPN - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Septerna|Shoshilinch likvidlik septerna.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
SEPN - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:Septerna Inc
Septerna Corp asosiy tovari

Ushbu ko'rsatkich real samaradorlikni baholash uchun bir martalik buxgalteriya tuzatishlarining ta'sirini istisno qilgan holda, biznesning sof moliyaviy natijasini aks ettiradi. Mazkur metrika kunlik pul oqimini qamrab oladi, bu esa konsolidatsiya bosqichlarini aniqlash va noto'g'ri bozor signallaridan qochish imkonini beradi. Septerna Inc (SEPN) uchun ushbu hisob-kitob vendorlar diversifikatsiyasi orqali molekula sintezini autsorsing qilish modelining barqarorligini tasdiqlaydi. Kompaniyaning foyda marjalarini tahlil qilish orqali investor operatsion faoliyatning barqarorligini aniqlaydi. Ushbu ko'rsatkichning tendentsiyasi aktivga kirishdan oldin filtr vazifasini o'taydi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN - Kompaniyaning sof foydasi|Sof moliyaviy natija Pharming Corp PHAR|NKTR: Sof foyda|Kompaniyaning sof daromadi upstreambio.com (UPB)|Kompaniyaning sof foydasi Zenas Biopharma|Immunome Inc - Soliqdan keyingi foyda|Sof daromad GOSS (Gossamer Corp)|Soliqlar to‘langandan keyingi foyda KALV|Sof foyda PVLA (Pieris Pharmaceuticals)|savarapharma.com (SVRA) - Kompaniyaning sof daromadi|RIGL - Kompaniyaning sof foydasi|Yakuniy foyda ANAB (AnaptysBio Inc)|Astria Pharma (ATXS) - Kompaniyaning sof foydasi|Kompaniya foydasi ENGN|RAPT (RAPT Therapeutics, Inc.) - Sof foyda|Sof foyda Aerovate|Sof daromad ACRS (Aclaris Therapeutics, Inc.)|KYTX (Kyverna Therapeutics Inc.) - Yakuniy foyda|Sof foyda TLSA (Tiziana Life Sciences PLC)|Sof moliyaviy natija Cabaletta Bio Inc (CABA)|VTYX - Kompaniyaning sof foydasi|THTX (theratech.com) - Kompaniya foydasi|AVTX: Sof foyda|Sof daromad Eledon Pharmaceuticals Inc.|Kompaniyaning sof foydasi Agenus Inc|Climb Bio, Inc (CLYM) - Sof moliyaviy natija|Sof foyda ZURA|ATYR - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Adagene Inc. ADAG|IMA (ImageneBio) - Soliqdan keyingi foyda|STTK - Kompaniyaning sof foydasi|EQ (Equillium, Inc.) - Kompaniya foydasi|connectbiopharm.com (CNTB) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda IMUX (Immunic)|ATRA (Atara Biotherapeutics, Inc.) - Sof foyda|IFRX: Yakuniy foyda|Sof foyda XFOR|Sof foyda adicetbio.com (ACET)|Kompaniyaning sof foydasi Celularity CELU|Yakuniy foyda INMB|BRNS - Kompaniyaning sof foydasi|Kezar Life Sciences Inc. (KZR) - Sof daromad|SABS: Sof foyda|Akari Therapeutics, Plc (AKTX) - Sof foyda|Sof daromad ENLV|QTTB: Yakuniy foyda|Sof foyda GOVX|Sof moliyaviy natija Edesa Biotech Inc|Kompaniyaning sof foydasi iBio Corp IBIO|CARM - Sof daromad|XTLB - Kompaniyaning sof foydasi|Bolt Biotherapeutics (BOLT) - Sof daromad|HCWB (hcwbiologics.com) - Sof daromad|Aptevo Therapeutics Inc. (APVO) - Sof foyda|Kompaniyaning sof foydasi AIM ImmunoTech|Kompaniya foydasi ADTX (Aditxt Corp)|Sof foyda GRI|XRTX - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Vyome Holdings HIND|Sof moliyaviy natija Revelation Biosciences Inc (REVB)|Indaptus - Sof foyda|Kompaniyaning sof daromadi BiondVax Pharmaceuticals|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda AFMD (Affimed N.V.)|Sof daromad ALLK|HOOK (HOOKIPA) - Soliqlar to‘langandan keyingi foyda|Sof foyda IGMS|ITOS - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|Yakuniy foyda TCBP|THRD - Kompaniyaning sof foydasi